12 Health Care Stocks Moving In Friday's Intraday Session
Gainers MDxHealth (NASDAQ:MDXH) stock moved upwards by 120.8% to $1.02 during Friday's regular session. The company's market cap stands at $23.7 million. The company's, Q2 earnings came out yesterday.
Benzinga21 days agoDARE
Daré Bioscience Announces $6M Offering Of 4,379,581 Shares (Or Pre-Funded Warrants To Purchase Shares Of Common Stock In Lieu Thereof) At $1.37/Share
Daré Bioscience, Inc. (NASDAQ:DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions, today announced that it has entered
Benzinga21 days agoDARE
Daré Bioscience, Inc. (DARE) Q2 2026 Earnings Call Transcript
Daré Bioscience, Inc. (DARE) Q2 2026 Earnings Call August 13, 2026 4:30 PM EDTCompany ParticipantsMarDee Haring-Layton - Chief Accounting OfficerSabrina...
SeekingAlpha22 days agoDARE
Stay updated with the stocks that are on the move in today's after-hours session.
The US market regular session of Thursday is over, let's have a look at the top gainers and losers in the after hours session today.
ChartMill22 days agoDARE
Dare Bioscience Reports Q2 2026 Results: Full Earnings Call Transcript
Dare Bioscience (NASDAQ:DARE) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time
Benzinga22 days agoDARE
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Akanda (NASDAQ:AKAN) stock rose 109.4% to $10.49 during Thursday's after-market session. The company's market cap stands at $2.9 million. Capricor Therapeutics (NASDAQ:CAPR) stock moved upwards by
Benzinga22 days agoDARE
Dare Bioscience Q2 EPS $(0.20) Beats $(0.24) Estimate, Sales $187.546K Beat $2.000K Estimate
Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.24) by 16.67 percent. This is a 55.56 percent increase over losses of $(0.45) per share from
Benzinga22 days agoDARE
Daré Bioscience, Inc. (DARE) Discusses Portfolio Advancements and Therapeutic Solutions for Women's Health Transcript
SeekingAlpha24 days agoDARE
Daré Bioscience, Inc. (DARE) Discusses Women's Health Portfolio and Commercialization Highlights on Virtual Bus Tour Transcript
Daré Bioscience, Inc. (DARE) Discusses Women's Health Portfolio and Commercialization Highlights on Virtual Bus Tour August 5, 2026 10:00 AM EDTCompany...
SeekingAlphalast monthDARE